Pharmafile Logo
Pharmafocus logo
Advanced Search

Charles River

Showing 7 posts of 7 posts found.

Contract research news in brief

November 12, 2012
Research and Development Bay Bioanalytical Laboratory, Bioclinica, Charles River, ICON, Pacific BioLabs, Quintiles, Vital River

Acquisitions for Charles River and Pacific BioLabs, a new contract for Bioclinica plus updates from Icon and Quintiles.

News

Contract research news in brief

September 4, 2012
Research and Development CRO, Charles River, WuXi

 Charles River Laboratories (CRL) has paid $17 million for Accugenix, a company which provides endotoxin detection and microbial identity testing …

News

WuXi posts buoyant increases in revenue and profit

May 13, 2010
Research and Development CRO, Charles River, Charles River Laboratories, WuXi

China’s WuXi PharmaTech has given would-be purchaser Charles River Laboratories a lift after posting buoyant increases in both revenues and …

News

Charles River to buy WuXi for $1.6bn

April 27, 2010
Research and Development Charles River, Charles River Laboratories, WuXi, contract research

Contract research and laboratory supplies giant Charles River has said it intends to purchase Chinese counterpart WuXi PharmaTech in a …

News

Charles River cuts forecasts as profits slump

August 11, 2009
Research and Development Charles River, preclinical

Contract preclinical testing specialist Charles River Laboratories saw its second-quarter sales drop 12.5% to $308 million as demand from pharmaceutical …

News

Charles River restructures as president sets retirement date

July 14, 2009
Research and Development CRO, Charles River

Charles River Laboratories has unveiled a major shake-up its business and sales activities as part of a reorganisation prompted by …

News

Quotient buys Scottish clinical unit from Charles River

May 26, 2009
Research and Development Charles River, Quotient

Contract research organisation Quotient Bioresearch has acquired a facility from Charles River Laboratories that will boost its capabilities in the …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025